Le Lézard
Classified in: Health
Subject: SVY

Flexible & Semi-Rigid Ureteroscopy Market Worth $1,054.1 Million by 2023


CHICAGO, September 21, 2018 /PRNewswire/ --

According to a new market research report "Flexible & Semi-Rigid Ureteroscopy Market by Product (Flexible Ureteroscopes, Semi-rigid Ureteroscopes), Application (Urolithiasis, Urinary Stricture, Kidney Cancer), End User (ASCS, Hospitals), and Region (US, Canada, Asia, Europe) - Global Forecast to 2023", published by MarketsandMarketstm, the market is expected to reach USD 1,054.1 million by 2023 from USD 809.6 million in 2018, at a CAGR of 5.4%.

     (Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg )

For more Insights on this report, Speak to Our Analyst:

https://www.marketsandmarkets.com/speaktoanalyst.asp?id=253934795

Factors such as the growing incidence of urolithiasis and technological advancements such as single-use ureteroscopes in flexible ureteroscopy are driving the growth of this market.

Flexible ureteroscopes are expected to account for the largest share of the market in 2018 

By type of product, the flexible & semi-rigid ureteroscopes market is further segmented into flexible and semi-rigid ureteroscopes. The flexible ureteroscopes segment is expected to account for the largest share in 2018. The growing incidence of urolithiasis, rising prevalence rate of kidney cancers, and technological advancements in flexible ureteroscopes are the primary factors driving the growth of the Flexible & Semi-Rigid Ureteroscopy Market. The flexible ureteroscopes market is further segmented into fiberoptic and digital ureteroscopes. The digital ureteroscopes segment is expected to account for the larger market share in 2018 owing to the higher efficacy and better image output of these devices.

Browse in-depth TOC on "Flexible & Semi-Rigid Ureteroscopy Market"

62 - Tables  

28 - Figures  

101 - Pages  

Urolithiasis applications to account for the largest share of the market in 2018 

By application, this market is classified into urolithiasis, urinary stricture, and kidney cancer. Urolithiasis is the largest application segment in the market owing to the increasing prevalence of urolithiasis globally.

https://www.marketsandmarkets.com/Market-Reports/flexible-semi-rigid-ureteroscopy-market-253934795.html

Hospitals are expected to dominate the flexible & semi-rigid ureteroscopy end-user market in 2018 

By end user, the Flexible & Semi-Rigid Ureteroscopy Market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment is expected to account for the largest share of the Flexible & Semi-Rigid Ureteroscopy Market. This large share can be attributed to the high number of surgeries performed in hospitals.

Request for PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=253934795

North America to command the largest share of the Flexible & Semi-Rigid Ureteroscopy Market in 2018 

By region, the Flexible & Semi-Rigid Ureteroscopy Market is geographically classified into North America, Europe, Asia, and the Rest of the World (RoW). North America is the largest regional market for ureteroscopes majorly due to the high prevalence of kidney stones (and the large number of surgical procedures performed for the same) and the rising healthcare expenditure in this region. Asia is expected to grow at the highest CAGR in the Flexible & Semi-Rigid Ureteroscopy Market during the forecast period. Growth in this region is mainly due to the large patient population.

Some of the major players operating in this market are Olympus (Japan), Stryker (US), Boston Scientific (US), KARL STORZ (Switzerland), Richard Wolf (Germany), ELMED Medical Systems (Turkey), Rocamed (France), Maxer Endoscopy (Germany), ProSurg (US), and Vimex Endoscopy (Poland).

Medical Devices Market Research Reports & Consulting 

About MarketsandMarketstm  

MarketsandMarketstm provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarketstm for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarketstm are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarketstm now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarketstm is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarketstm INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/flexible-semi-rigid-ureteroscopy-market.asp


SOURCE MarketsandMarkets


These press releases may also interest you

at 18:50
Getting specialty medications into...

at 18:30
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

at 18:23
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

at 17:55
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...



News published on and distributed by: